Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.
Bao H, Wang Z, Ma X, Guo W, Zhang X, Tang W, Chen X, Wang X, Chen Y, Mo S, Liang N, Ma Q, Wu S, Xu X, Chang S, Wei Y, Zhang X, Bao H, Liu R, Yang S, Jiang Y, Wu X, Li Y, Zhang L, Tan F, Xue Q, Liu F, Cai S, Gao S, Peng J, Zhou J, Shao Y.
Bao H, et al. Among authors: liu r, liu f.
Mol Cancer. 2022 Jun 11;21(1):129. doi: 10.1186/s12943-022-01594-w.
Mol Cancer. 2022.
PMID: 35690859
Free PMC article.
Clinical Trial.